Skip to content
★ Sign in to follow
CL

Carl LeBel

Directeur du Développement
Korro Bio, Inc.Otonomy, Inc.
Total declarations
29
Companies
2
▲ Purchases (0 ops.)
—
▼ Sales (14 ops.)
€1.6M

Latest filing published 07 Jul 2022 for Korro Bio, Inc., €6,597.

Filing timeline

BuySale
Carl LeBel

Insider track record

Disclosed buys
0
Disclosed sells
14
Signal history

Carl LeBel: trading record in brief

Carl LeBel is a declared insider at 2 companies (senior executive); the most frequent names are Otonomy, Inc. and Korro Bio, Inc. Over a trading history stretching from 1 June 2015 to 6 July 2022, the count stands at 29 filings.

On the market, this insider has only sold: 14 sales, €1.6M in total. Besides market trades, the filings include 3 share grants and 12 option exercises. Since January 2022: no purchases and 6 sales on the market.

The record was last updated on 7 July 2022 with an open-market sale (€6,597) in Korro Bio, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. For comparison, the SEC allows two business days to file a Form 4. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.

Companies and markets linked to Carl LeBel

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations29 total
  • ▼
    Chief Development OfficerExecutivesKorro Bio, Inc.
    6,720 USD32SEC
    4,421 shares@ US$1.5228.6% of flowCommon StockSEC:0001127602-22-019045:1
  • ◇
    Chief Development OfficerExecutivesKorro Bio, Inc.
    0SEC
    15,000 sharesCommon StockSEC:0001127602-22-019045:0
  • ▼
    Chief Development OfficerExecutivesKorro Bio, Inc.
    3,774 USD30SEC
    1,069 shares@ US$3.5314.5% of flowCommon StockSEC:0001127602-22-006321:1
  • ▼
    Chief Development OfficerExecutivesKorro Bio, Inc.
    3,772 USD34SEC
    974 shares@ US$3.87350.6% of flowCommon StockSEC:0001127602-22-006321:0
  • ▼
    Chief Development OfficerExecutivesKorro Bio, Inc.
    3,775 USD30SEC
    901 shares@ US$4.1914.4% of flowCommon StockSEC:0001127602-22-005750:1
  • ▼
    Chief Development OfficerExecutivesKorro Bio, Inc.
    3,681 USD34SEC
    831 shares@ US$4.42949.4% of flowCommon StockSEC:0001127602-22-005750:0
  • ▼
    Chief Development OfficerExecutivesKorro Bio, Inc.
    3,655 USD30SEC
    844 shares@ US$4.3314.0% of flowCommon StockSEC:0001127602-22-005336:1
  • ◇
    Chief Development OfficerExecutivesKorro Bio, Inc.
    0SEC
    15,000 sharesCommon StockSEC:0001127602-22-005336:0
  • ◇
    Chief Scientific OfficerExecutivesOtonomy, Inc.
    22,427 USD11SEC
    3,543 shares@ US$6.333.1% of flowCommon StockSEC:0001209191-16-151770:0
  • ◇
    Chief Scientific OfficerExecutivesOtonomy, Inc.
    17,834 USD11SEC
    5,626 shares@ US$3.172.5% of flowCommon StockSEC:0001209191-16-151770:1
  • ▼
    Chief Scientific OfficerExecutivesOtonomy, Inc.
    165,684 USD13SEC
    9,169 shares@ US$18.0723.2% of flowCommon StockSEC:0001209191-16-151770:2
  • ◇
    Chief Scientific OfficerExecutivesOtonomy, Inc.
    4,616 USD11SEC
    1,456 shares@ US$3.170.6% of flowCommon StockSEC:0001209191-16-151770:3
  • ▼
    Chief Scientific OfficerExecutivesOtonomy, Inc.
    26,310 USD11SEC
    1,456 shares@ US$18.073.7% of flowCommon StockSEC:0001209191-16-151770:4
  • ◆
    Chief Scientific OfficerExecutivesOtonomy, Inc.
    3,577 USD11SEC
    263 shares@ US$13.600.5% of flowCommon StockSEC:0001209191-16-140652:0
  • ◆
    Chief Scientific OfficerExecutivesOtonomy, Inc.
    3,611 USD11SEC
    275 shares@ US$13.130.5% of flowCommon StockSEC:0001209191-16-140652:1
  • ◇
    Chief Scientific OfficerExecutivesOtonomy, Inc.
    76,802 USD12SEC
    12,133 shares@ US$6.3310.1% of flowCommon StockSEC:0001209191-16-140652:2
  • ◇
    Chief Scientific OfficerExecutivesOtonomy, Inc.
    24,136 USD11SEC
    3,813 shares@ US$6.333.2% of flowCommon StockSEC:0001209191-16-140652:3
  • ◇
    Chief Scientific OfficerExecutivesOtonomy, Inc.
    16,814 USD11SEC
    5,304 shares@ US$3.172.2% of flowCommon StockSEC:0001209191-16-140652:4
  • ▼
    Chief Scientific OfficerExecutivesOtonomy, Inc.
    217,787 USD14SEC
    12,133 shares@ US$17.9528.7% of flowCommon StockSEC:0001209191-16-140652:5
  • ▼
    Chief Scientific OfficerExecutivesOtonomy, Inc.
    68,443 USD12SEC
    3,813 shares@ US$17.959.0% of flowCommon StockSEC:0001209191-16-140652:6
  • ▼
    Chief Scientific OfficerExecutivesOtonomy, Inc.
    95,207 USD12SEC
    5,304 shares@ US$17.9512.6% of flowCommon StockSEC:0001209191-16-140652:7
  • ◇
    Chief Scientific OfficerExecutivesOtonomy, Inc.
    104,926 USD0SEC
    16,576 shares@ US$6.33Common StockSEC:0001209191-15-086708:0
  • ◇
    Chief Scientific OfficerExecutivesOtonomy, Inc.
    14,817 USD0SEC
    4,674 shares@ US$3.17Common StockSEC:0001209191-15-086708:1
  • ▼
    Chief Scientific OfficerExecutivesOtonomy, Inc.
    367,050 USD0SEC
    13,189 shares@ US$27.83Common StockSEC:0001209191-15-086708:2
  • ▼
    Chief Scientific OfficerExecutivesOtonomy, Inc.
    228,771 USD0SEC
    8,061 shares@ US$28.38Common StockSEC:0001209191-15-086708:3

25 of 29 declarations